We are live on
!
Find out more
EM
Excalibur Management Portfolio holdings
AUM
$278M
1-Year Est. Return
20.09%
This Fund
S&P 500
This Quarter
Est. Return
+0.54%
1 Year Est. Return
+20.09%
3 Year Est. Return
+68.93%
5 Year Est. Return
+93.63%
10 Year Est. Return
+240.99%
AUM
$80.6M
AUM Growth
–
Cap. Flow
+$81.4M
Cap. Flow
% of AUM
101.08%
Top 10 Holdings %
Top 10 Hldgs %
62.77%
Holding
57
New
57
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$8.22M |
| 2 |
Verizon
VZ
|
+$8.08M |
| 3 |
Carlisle Companies
CSL
|
+$6.98M |
| 4 |
Johnson & Johnson
JNJ
|
+$5.74M |
| 5 |
Pfizer
PFE
|
+$5.51M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.81% |
| 2 | Communication Services | 19.96% |
| 3 | Industrials | 13.9% |
| 4 | Consumer Staples | 10.02% |
| 5 | Technology | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Verizon
VZ
$201B
| $7.97M | 9.89% |
+158,247
| New | +$8.08M |
|
|
2
AT&T
T
$169B
| $7.91M | 9.82% |
+295,819
| New | +$8.22M |
|
|
3
Carlisle Companies
CSL
$14.1B
| $6.65M | 8.26% |
+106,749
| New | +$6.98M |
|
|
4
Johnson & Johnson
JNJ
$643B
| $5.81M | 7.21% |
+67,643
| New | +$5.74M |
|
|
5
Pfizer
PFE
$144B
| $5.3M | 6.58% |
+199,483
| New | +$5.51M |
|
6
Merck
MRK
$326B
| $4.75M | 5.9% |
+107,275
| New | +$4.79M |
|
7
GE Aerospace
GE
$377B
| $4.11M | 5.1% |
+36,963
| New | +$4.09M |
|
8
ExxonMobil
XOM
$634B
| $2.89M | 3.59% |
+31,997
| New | +$2.88M |
|
9
Microsoft
MSFT
$2.92T
| $2.76M | 3.43% |
+79,932
| New | +$2.62M |
|
10
PepsiCo
PEP
$195B
| $2.42M | 3.01% |
+29,652
| New | +$2.42M |
|
11
Berkshire Hathaway Class B
BRK.B
$1.11T
| $2.08M | 2.58% |
+18,573
| New | +$2.04M |
|
12
Procter & Gamble
PG
$347B
| $1.87M | 2.32% |
+24,261
| New | +$1.9M |
|
13
Independent Bank
INDB
$4.1B
| $1.8M | 2.23% |
+52,105
| New | +$1.68M |
|
14
Coca-Cola
KO
$380B
| $1.67M | 2.07% |
+41,575
| New | +$1.72M |
|
15
Southern Company
SO
$109B
| $1.36M | 1.69% |
+30,776
| New | +$1.42M |
|
16
Duke Energy
DUK
$101B
| $1.16M | 1.44% |
+17,213
| New | +$1.22M |
|
17
Bristol-Myers Squibb
BMY
$130B
| $1.15M | 1.42% |
+25,665
| New | +$1.11M |
|
|
EMC
18
DELISTED
EMC CORPORATION
EMC
| $1.11M | 1.38% |
+47,115
| New | +$1.11M |
|
|
KMP
19
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
| $1.05M | 1.3% |
+12,305
| New | +$1.07M |
|
20
Intel
INTC
$435B
| $1.03M | 1.28% |
+42,574
| New | +$1.01M |
|
21
IBM
IBM
$214B
| $1.03M | 1.28% |
+5,645
| New | +$1.1M |
|
22
State Street SPDR S&P 500 ETF Trust
SPY
$783B
| $1.02M | 1.26% |
+6,349
| New | +$1.02M |
|
23
ConocoPhillips
COP
$139B
| $926K | 1.15% |
+15,305
| New | +$931K |
|
24
AbbVie
ABBV
$465B
| $836K | 1.04% |
+20,225
| New | +$885K |
|
25
Philip Morris
PM
$312B
| $803K | 1% |
+9,266
| New | +$861K |
|
Similar funds
DI
CC
CB
ACP
SL
LJCM
KWM
RW
Excalibur Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Excalibur Management, which disclosed 57 positions worth $80.6M. Its ten largest holdings account for 63% of the portfolio.
Its largest position is AT&T: 295,819 shares worth $7.91M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Communication Services and Industrials.
- Excalibur Management's largest Q2 2013 buy was AT&T: 295,819 shares worth $7.91M.
- Excalibur Management's ten largest holdings make up 63% of its $80.6M portfolio in Q2 2013.
- Excalibur Management disclosed 57 positions in Q2 2013, its first 13F filing on record.
Based on Excalibur Management's 13F filing for Q2 2013, filed 9 Aug 2013.